ARQT Award Disclosure
Peetz Christopher · SEC Form 4 · Filed Jul 17, 2026
Award
Calculated transaction value
$0
Peetz Christopher Director
ARQT
Transaction date
Jul 15, 2026
Public filing date
Jul 17, 2026
Filing lag
Filed 2 days later
ARQT daily price context
Close on/before transaction
$27.78
Jul 15, 2026
Close before public filing
$27.74
Jul 16, 2026
Return since public filing
-13.59%
Through Aug 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 13,010 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001628280-26-048655
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | Award | Jul 15, 2026 | $0 |
| Arcutis Biotherapeutics, Inc. ARQT | Award | Jul 15, 2026 | $0 |
| Arcutis Biotherapeutics, Inc. ARQT Current | Award | Jul 15, 2026 | $0 |